Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Cancer Res. 2011 Sep 6;71(21):6764–6772. doi: 10.1158/0008-5472.CAN-11-0691

Figure 3. Itraconazole inhibits EGM-2, VEGF, and bFGF stimulated HUVEC tube formation.

Figure 3

HUVEC stimulated with EGM-2, 10 ng/ml VEGF, or 12 ng/ml bFGF were allowed to spontaneously form tube networks after treatment with vehicle control, 0.1 µM, 0.6 µM, or 3.0 µM itraconazole. Unstimulated (basal media) HUVEC serve as negative control. Resulting networks were visualized with calcein-AM.

HHS Vulnerability Disclosure